ROYAL BANK OF CANADA - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$222,000
+54.2%
10,813
+49.5%
0.00%
Q2 2023$144,000
-92.0%
7,234
-93.1%
0.00%
Q1 2023$1,795,000
+784.2%
104,765
+909.0%
0.00%
Q4 2022$203,000
+2155.6%
10,383
+1848.0%
0.00%
Q3 2022$9,000
-96.5%
533
-97.2%
0.00%
Q2 2022$259,000
+547.5%
18,829
+643.3%
0.00%
Q1 2022$40,000
-79.5%
2,533
-71.7%
0.00%
Q4 2021$195,000
+91.2%
8,941
+162.3%
0.00%
Q3 2021$102,000
-15.0%
3,409
+25.3%
0.00%
Q2 2021$120,000
-92.5%
2,720
-92.4%
0.00%
Q1 2021$1,592,000
+19800.0%
35,886
+26286.8%
0.00%
Q4 2020$8,000
+300.0%
136
-9.3%
0.00%
Q1 2020$2,000
-92.3%
150
-86.7%
0.00%
Q4 2019$26,000
+62.5%
1,124
+77.0%
0.00%
Q3 2018$16,000
-52.9%
635
-63.5%
0.00%
Q2 2018$34,000
-24.4%
1,741
-27.3%
0.00%
Q1 2018$45,0002,3940.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders